Chong Chen - Publications

Affiliations: 
Sichuan University, Chengdu Shi, Sichuan Sheng, China 
Area:
Cancer

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Xu J, Zhong A, Zhang S, Chen M, Zhang L, Hang X, Zheng J, Wu B, Deng X, Pan X, Wang Z, Qi L, Shi K, Li S, Wang Y, ... ... Chen C, et al. KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2206098. PMID 37142882 DOI: 10.1002/advs.202206098  0.303
2022 Na F, Pan X, Chen J, Chen X, Wang M, Chi P, You L, Zhang L, Zhong A, Zhao L, Dai S, Zhang M, Wang Y, Wang B, Zheng J, ... ... Chen C, et al. KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming. Nature Cancer. PMID 35449309 DOI: 10.1038/s43018-022-00361-6  0.405
2020 Chen M, Chen X, Li S, Pan X, Gong Y, Zheng J, Xu J, Zhao C, Zhang Q, Zhang S, Qi L, Wang Z, Shi K, Ding BS, Xue Z, ... ... Chen C, et al. An epigenetic mechanism underlying chromosome 17p deletion-driven tumorigenesis. Cancer Discovery. PMID 32978226 DOI: 10.1158/2159-8290.CD-20-0336  0.44
2018 Zheng P, Zhang Y, Ye P, Wu W, Chen C, Liu Y. Cd24 Defects Recapitulates Features of Aging Hematopoiesis Biology of Blood and Marrow Transplantation. 24: S477-S478. DOI: 10.1016/j.bbmt.2017.12.573  0.398
2017 Liu Y, Chen C, Xu Z, Niu T, Lowe S. The impact of ALOX cluster loss in chromosome 17p deletions on cancer Genes and Diseases. 4: 12-13. DOI: 10.1016/J.Gendis.2016.10.008  0.355
2016 Liu Y, Chen C, Xu Z, Scuoppo C, Rillahan CD, Gao J, Spitzer B, Bosbach B, Kastenhuber ER, Baslan T, Ackermann S, Cheng L, Wang Q, Niu T, Schultz N, et al. Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. Nature. PMID 26982726 DOI: 10.1038/Nature17157  0.418
2015 Ye P, Liu Y, Chen C, Tang F, Wu Q, Wang X, Liu CG, Liu X, Liu R, Liu Y, Zheng P. An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation. Molecular Cell. 57: 708-20. PMID 25639470 DOI: 10.1016/j.molcel.2014.12.034  0.581
2015 Ye P, Liu Y, Chen C, Tang F, Wu Q, Wang X, Liu CG, Liu X, Liu R, Liu Y, Zheng P. An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation. Molecular Cell. 57: 708-20. PMID 25639470 DOI: 10.1016/j.molcel.2014.12.034  0.581
2015 Appelmann I, Rillahan CD, de Stanchina E, Carbonetti G, Chen C, Lowe SW, Sherr CJ. Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL. Blood. 125: 1444-51. PMID 25499760 DOI: 10.1182/Blood-2014-09-601062  0.411
2015 Wong C, Chen C, Wu Q, Liu Y, Zheng P. A critical role for the regulated wnt-myc pathway in naive T cell survival. Journal of Immunology (Baltimore, Md. : 1950). 194: 158-67. PMID 25429066 DOI: 10.4049/jimmunol.1401238  0.629
2015 Wong C, Chen C, Wu Q, Liu Y, Zheng P. A critical role for the regulated wnt-myc pathway in naive T cell survival. Journal of Immunology (Baltimore, Md. : 1950). 194: 158-67. PMID 25429066 DOI: 10.4049/jimmunol.1401238  0.629
2014 Chen C, Liu Y, Rappaport AR, Kitzing T, Schultz N, Zhao Z, Shroff AS, Dickins RA, Vakoc CR, Bradner JE, Stock W, LeBeau MM, Shannon KM, Kogan S, Zuber J, et al. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia Cancer Cell. 25: 652-665. PMID 24794707 DOI: 10.1016/J.Ccr.2014.03.016  0.385
2013 Lu C, Venneti S, Akalin A, Fang F, Ward PS, Dematteo RG, Intlekofer AM, Chen C, Ye J, Hameed M, Nafa K, Agaram NP, Cross JR, Khanin R, Mason CE, et al. Induction of sarcomas by mutant IDH2. Genes & Development. 27: 1986-98. PMID 24065766 DOI: 10.1101/Gad.226753.113  0.442
2013 Chen C, Liu Y, Lu C, Cross JR, Morris JP, Shroff AS, Ward PS, Bradner JE, Thompson C, Lowe SW. Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition. Genes & Development. 27: 1974-85. PMID 24065765 DOI: 10.1101/Gad.226613.113  0.455
2012 Chen G, Chen X, King S, Cavassani KA, Cheng J, Zheng X, Cao H, Yu H, Qu J, Fang D, Wu W, Bai X, Liu J, Woodiga SA, Chen C, et al. Erratum: Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction Nature Biotechnology. 30: 193-193. DOI: 10.1038/Nbt0212-193B  0.408
2011 Zuber J, Rappaport AR, Luo W, Wang E, Chen C, Vaseva AV, Shi J, Weissmueller S, Fellmann C, Fellman C, Taylor MJ, Weissenboeck M, Graeber TG, Kogan SC, Vakoc CR, et al. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes & Development. 25: 1628-40. PMID 21828272 DOI: 10.1101/Gad.17269211  0.444
2011 Wu Q, Liu Y, Chen C, Ikenoue T, Qiao Y, Li CS, Li W, Guan KL, Liu Y, Zheng P. The tuberous sclerosis complex-mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 1106-12. PMID 21709159 DOI: 10.4049/Jimmunol.1003968  0.611
2011 Wu Q, Liu Y, Chen C, Ikenoue T, Qiao Y, Li CS, Li W, Guan KL, Liu Y, Zheng P. The tuberous sclerosis complex-mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 1106-12. PMID 21709159 DOI: 10.4049/Jimmunol.1003968  0.611
2011 Chen GY, Chen X, King S, Cavassani KA, Cheng J, Zheng X, Cao H, Yu H, Qu J, Fang D, Wu W, Bai XF, Liu JQ, Woodiga SA, Chen C, et al. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nature Biotechnology. 29: 428-35. PMID 21478876 DOI: 10.1038/Nbt.1846  0.583
2011 Chen GY, Chen X, King S, Cavassani KA, Cheng J, Zheng X, Cao H, Yu H, Qu J, Fang D, Wu W, Bai XF, Liu JQ, Woodiga SA, Chen C, et al. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nature Biotechnology. 29: 428-35. PMID 21478876 DOI: 10.1038/Nbt.1846  0.583
2010 Li CS, Chen C, Zheng P, Liu Y. Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis. Plos One. 5: e13439. PMID 20976169 DOI: 10.1371/Journal.Pone.0013439  0.607
2010 Li CS, Chen C, Zheng P, Liu Y. Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis. Plos One. 5: e13439. PMID 20976169 DOI: 10.1371/Journal.Pone.0013439  0.607
2010 Chen C, Liu Y, Liu Y, Zheng P. Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. The Journal of Clinical Investigation. 120: 4091-101. PMID 20972332 DOI: 10.1172/JCI43873  0.604
2010 Chen C, Liu Y, Liu Y, Zheng P. Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. The Journal of Clinical Investigation. 120: 4091-101. PMID 20972332 DOI: 10.1172/JCI43873  0.604
2009 Chen C, Liu Y, Liu Y, Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Science Signaling. 2: ra75. PMID 19934433 DOI: 10.1126/scisignal.2000559  0.608
2009 Chen C, Liu Y, Liu Y, Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Science Signaling. 2: ra75. PMID 19934433 DOI: 10.1126/scisignal.2000559  0.608
2009 Wang L, Liu R, Li W, Chen C, Katoh H, Chen GY, McNally B, Lin L, Zhou P, Zuo T, Cooney KA, Liu Y, Zheng P. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell. 16: 336-46. PMID 19800578 DOI: 10.1016/J.Ccr.2009.08.016  0.557
2009 Wang L, Liu R, Li W, Chen C, Katoh H, Chen GY, McNally B, Lin L, Zhou P, Zuo T, Cooney KA, Liu Y, Zheng P. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell. 16: 336-46. PMID 19800578 DOI: 10.1016/J.Ccr.2009.08.016  0.557
2009 Liu R, Wang L, Chen G, Katoh H, Chen C, Liu Y, Zheng P. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. Cancer Research. 69: 2252-9. PMID 19276356 DOI: 10.1158/0008-5472.CAN-08-3717  0.584
2009 Liu R, Wang L, Chen G, Katoh H, Chen C, Liu Y, Zheng P. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. Cancer Research. 69: 2252-9. PMID 19276356 DOI: 10.1158/0008-5472.CAN-08-3717  0.584
2009 Chen C, Liu Y, Liu Y, Zheng P. The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells. Cell Cycle (Georgetown, Tex.). 8: 1158-60. PMID 19270502 DOI: 10.4161/cc.8.8.8139  0.603
2009 Chen C, Liu Y, Liu Y, Zheng P. The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells. Cell Cycle (Georgetown, Tex.). 8: 1158-60. PMID 19270502 DOI: 10.4161/cc.8.8.8139  0.603
2008 Liu R, Wang L, Chen C, Liu Y, Zhou P, Wang Y, Wang X, Turnbull J, Minassian BA, Liu Y, Zheng P. Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms. Molecular and Cellular Biology. 28: 7236-44. PMID 18824542 DOI: 10.1128/Mcb.01334-08  0.583
2008 Liu R, Wang L, Chen C, Liu Y, Zhou P, Wang Y, Wang X, Turnbull J, Minassian BA, Liu Y, Zheng P. Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms. Molecular and Cellular Biology. 28: 7236-44. PMID 18824542 DOI: 10.1128/Mcb.01334-08  0.583
2008 Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Liu Y, Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. The Journal of Experimental Medicine. 205: 2397-408. PMID 18809716 DOI: 10.1084/Jem.20081297  0.614
2008 Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Liu Y, Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. The Journal of Experimental Medicine. 205: 2397-408. PMID 18809716 DOI: 10.1084/Jem.20081297  0.614
2008 Chen GY, Chen C, Wang L, Chang X, Zheng P, Liu Y. Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 5163-6. PMID 18390696 DOI: 10.4049/jimmunol.180.8.5163  0.629
2008 Chen GY, Chen C, Wang L, Chang X, Zheng P, Liu Y. Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 5163-6. PMID 18390696 DOI: 10.4049/jimmunol.180.8.5163  0.629
2008 Chen C, Liu Y, Liu R, Ikenoue T, Guan K, Liu Y, Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species The Journal of Cell Biology. 183: i1-i1. DOI: 10.1083/JCB1831OIA1  0.459
Show low-probability matches.